Cargando…
Drug resistance features and S-phase fraction as possible determinants for drug response in a panel of human ovarian cancer xenografts
Multidrug resistance (MDR) and more specifically the expression of P-glycoprotein (Pgp) have been studied extensively in vitro. Unfortunately, it appears that the predictive value of MDR recognized in vitro is mostly an incorrect measure to determine the responsiveness of a particular tumour in the...
Autores principales: | Kolfschoten, G M, Hulscher, T M, Pinedo, H M, Boven, E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374672/ https://www.ncbi.nlm.nih.gov/pubmed/10970695 http://dx.doi.org/10.1054/bjoc.2000.1373 |
Ejemplares similares
-
The anti-tumour effects of the prodrugs N-l-leucyl-doxorubicin and vinblastine-isoleucinate in human ovarian cancer xenografts.
por: Boven, E., et al.
Publicado: (1992) -
Characterization of human soft-tissue sarcoma xenografts for use in secondary drug screening.
por: Boven, E., et al.
Publicado: (1998) -
The efficacy of the anthracycline prodrug daunorubicin-GA3 in human ovarian cancer xenografts.
por: Houba, P. H., et al.
Publicado: (1998) -
Acquisition of platinum drug resistance and platinum cross resistance patterns in a panel of human ovarian carcinoma xenografts.
por: Jones, M., et al.
Publicado: (1993) -
Comparison of monoclonal antibodies 17-1A and 323/A3: the influence of the affinity on tumour uptake and efficacy of radioimmunotherapy in human ovarian cancer xenografts.
por: Kievit, E., et al.
Publicado: (1996)